H.R. 2344 · 117th Congress · House

Prescription Drug Monitoring Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Apr 1, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Prescription Drug Monitoring Act of 2021

This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.

States or territories that receive this funding must require

  • prescribers to consult the PDMP before starting treatment with such drugs, and
  • dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.

In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.

Action Timeline

4
  1. APR 02, 2021Committee

    Referred to the Subcommittee on Health.

  2. APR 01, 2021IntroReferral

    Introduced in House

  3. APR 01, 2021IntroReferral

    Introduced in House

  4. APR 01, 2021IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Apr 2, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Apr 1, 2021

Active